Propofol

Product description

Propofol is a short and rapid-acting general anesthetic with narcotic and sedative properties. It is administered intravenously for anesthesia and sedation during intensive care and is often used in combination with the analgesic Remifentanil.

Comprehensive documentation for drug registration of Propofol can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
2078-54-8 CEP, ASMF EP, USP

Tradename(s)

Propofol (Anesthetic)

Country availability

Available worldwide

Georges Bertagne

Contact person

Georges Bertagne

General Manager


email   phone

Contact person

Brigitte Favre Bonnefoy

Head of Sales


email   phone